Kenan Anna, Kurien Anila Abraham, Gonzalez Manuel, Alexander Kyrstin, Kumar Anjushree, Qaqish Ibrahim, Caza Tiffany
Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Renopath Center for Renal and Urological Pathology, Chennai, Tamil Nadu, India.
Am J Transplant. 2025 Apr;25(4):860-866. doi: 10.1016/j.ajt.2024.11.026. Epub 2024 Nov 28.
Membranous nephropathy (MN) is a major cause of nephrotic syndrome, and neural epidermal growth factor-like 1 protein (NELL1) is the second most common inciting antigen. An increasing number of exposures and diseases have been associated with NELL1 MN. There are limited data on NELL1 following kidney transplantation with only 1 previously reported case. In this report, we describe 3 cases of recurrent and 3 cases of de novo NELL1 MN. None of the patients in this series had known triggers of MN, such as malignancy or associated medications (including lipoic acid, bucillamine, tiotropin, or indigenous medicines). This suggests that NELL1, although not a podocyte antigen, may present as an idiopathic disease or transplantation may serve as an exposure for the development of NELL1 MN.
膜性肾病(MN)是肾病综合征的主要病因,神经表皮生长因子样1蛋白(NELL1)是第二常见的致病抗原。越来越多的暴露因素和疾病与NELL1相关性MN有关。肾移植后关于NELL1的数据有限,此前仅报告过1例病例。在本报告中,我们描述了3例复发性NELL1 MN和3例新发NELL1 MN。该系列患者均无已知的MN触发因素,如恶性肿瘤或相关药物(包括硫辛酸、青霉胺、噻托溴铵或本土药物)。这表明,NELL1虽然不是足细胞抗原,但可能表现为特发性疾病,或者移植可能是NELL1 MN发生的一个暴露因素。